Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04481373 · ClinicalTrials.gov registry record · NA
Targeting HIV Retention and Improved Viral Load Through Engagement ('THRIVE')
A NA study, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 75
- Enrollment target
NCT04481373 is a NA study that has completed, run by Baylor College of Medicine. The registered enrollment target is 75 participants.
The verdict
NCT04481373, a NA study, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
Study Summary
Many people with HIV infection are not consistently engaged in outpatient HIV care, and avoidance, stigma and denial contribute to poor engagement in HIV care. This project will develop and pilot test a new intervention, "THRIVE," for hospitalized persons who are out of HIV care and endorse avoidance, to improve how well they stay in outpatient HIV care after discharge. If successfully developed, the intervention will undergo large scale testing in later studies and could improve the health of persons with HIV infection and help end the HIV epidemic in the United States.
Interventions
- OTHER Treatment as Usual
- BEHAVIORAL THRIVE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2021-03-03 |
| Est. Completion | 2024-02-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04481373
The ClinicalTrials.gov registry entry for NCT04481373 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Treatment as Usual is the first listed.
NCT04481373 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04481373 about?
NCT04481373 is a clinical study titled "Targeting HIV Retention and Improved Viral Load Through Engagement ('THRIVE')". Many people with HIV infection are not consistently engaged in outpatient HIV care, and avoidance, stigma and denial contribute to poor engagement in HIV care. This project will develop and pilot test a new intervention, "THRIVE," for hospitalized persons who are out of HIV care and endorse avoidanc...
What is the current status of trial NCT04481373?
This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2021-03-03. Estimated completion is 2024-02-29.
What interventions are being tested in trial NCT04481373?
The interventions under investigation include: Treatment as Usual (OTHER), THRIVE (BEHAVIORAL).
Who is sponsoring clinical trial NCT04481373?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.